​​​​Day 2 – Thursday, January 15, 2026

​

8:00 AM – 8:30 AM | Registration

​

8:30 AM – 8:40 AM | Opening Welcome and Introductions

Welcome remarks by congress chairs and BEWA founders

 

8:40 AM – 9:00 AM | Opening Lecture

Obesity as a chronic disease / Francesco Rubino

​

9:00 AM – 10:30 AM | Live Surgery Session

Live and pre-recorded demonstration of cutting-edge endobariatric procedures.

 

10:30 AM – 11:00 AM | Coffee Break & networking with Partners / Exhibitors

 

11:00 AM – 12:30 PM | Scientific Session: Endoscopic Therapies – Evidence & Evolution

Chairs: C. Stier, S. Pichamol Jirapinyo

• ESG – Current global status / Christine Stier

• POSE, POSE 2.0 – Mega Evidence and evolution / Roman Turro

• Endomina – Evidence, long-term data and Evolution / Vincent Huberty

• Endozip: technique and initial results / Ivo Boskoski

• ESG+: GEM and BEAM / Christopher Thompson 

• Gastric Fundus Mucosal ablation alone and with ESG: the evidence/ Ivo Boskoski

• Gastroplasty : the journey towards standardization / Barham Abu Dayyeh

• Society guidelines on gastric interventions and peri-procedural management / Sigh Pichamol Jirapinyo

 

12:30 PM – 1:30 PM | Lunch Break & networking with Partners / Exhibitors

 

1:30 PM - 2:00 PM Patient Selection with live voting

Chairs: F. Pattou, C. Stier

• Who is the Best Candidate for Bariatric endoscopy? / Manoel Galvao Neto (visioconference)

• Who is the Best Candidate for Metabolic endoscopy? / Barham Abu Dayyeh

• Who is the Best Candidate for Anti-obesity medications? / Sigh Pichamol Jirapinyo

• Who is the Best Candidate for Surgery? / Mohit Bhandari

• Treat to Target in Obesity / François Pattou

• Neoadjuvant Endoscopy in the Transplant Pathway: Indications in Obese Patients / Ivo Boskoski

 

2:00 PM – 3:00 PM | Metabolic Endoscopy – Evidence & Evolution

Duodenal Targeted Therapies

Chairs: F. Rubino, R. Haidry, E. Capristo

• Duodenal Mucosal Resurfacing (DMR) / Ivo Boskoski

• Electroporation (RECET) / Barham Abu Dayyeh

• Vapor Ablation / Rehan Haidry

• Endo-bypass Liners / Manoel Galvao Neto (visionconference)

• Endoscopic Pancreatic Gene Therapy (Rejuva) / Christopher Thompson 

 

3:00 PM – 3:30 PM | Coffee Break & Networking with Partners / Exhibitors

​

3:30 PM –5:30 PM | Gut Hormone Modulation and Other Metabolic Therapies Beyond Diabetes

Moderators Mixed panel:  / F. Rubino, E. Capristo, B. Abu Dayyeh, F. Pattou, R. Caiazzo

Dual Therapy: Endoscopy + GLP-1s – The Synergy Model

• GLP-1s Effects on satiety, weight loss kinetics, and comorbidities / Esmeralda Capristo 

• Endoscopic management of MASLD/MASH: the evidence / Sigh Pichamol Jirapinyo 

• Evidence for combining EMBT with Drugs / Rehan Haidry

• Cost: the elephant in the room: Insurance coverage for EBMTs and GLP-1s across the globe / Christopher Thompson 

• Can genetics and machine learning predict who responds best to EMT or anti-obesity medications? / Barham Abu Dayyeh

 

Panel discussion: Beyond the Scope: What Outcomes Matter Most to Endocrinologists, Hepatologists, and Patients?

​

Keynote lecture: The Future of Bariatric and Metabolic Therapy: cut, swallow, or scope? / Robert Caiazzo

 

7:30 PM – 9:30 PM | Congress Dinner with Participants and Partners​​​